These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Incidental finding of ileal gastrointestinal stromal tumour during prostate cancer staging with prostate-specific membrane antigen scan. Lee DJW; Warner M; Shannon T; Moschilla J J Med Imaging Radiat Oncol; 2021 Feb; 65(1):89-91. PubMed ID: 33118296 [TBL] [Abstract][Full Text] [Related]
49. More than the prostate: Intrapancreatic accessory spleen and papillary thyroid cancer detected with Singh D; Horneman R; Nagra NK Hell J Nucl Med; 2018; 21(2):145-147. PubMed ID: 30006647 [TBL] [Abstract][Full Text] [Related]
50. Effective Prostate-Specific Membrane Antigen-Based 18F-DCFPyL-Guided Cryoablation of a Single Positive Site in a Patient Believed to Be More Metastatic on 11C-Choline PET/CT. Cornelis FH; Durack JC; Morris MJ; Scher HI; Solomon SB Clin Nucl Med; 2017 Dec; 42(12):e516-e518. PubMed ID: 29099733 [TBL] [Abstract][Full Text] [Related]
51. Diagnostic Accuracy of Cantiello F; Gangemi V; Cascini GL; Calabria F; Moschini M; Ferro M; Musi G; Butticè S; Salonia A; Briganti A; Damiano R Urology; 2017 Aug; 106():139-145. PubMed ID: 28438628 [TBL] [Abstract][Full Text] [Related]
52. Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer. Ceci F; Castellucci P; Fanti S Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):7-18. PubMed ID: 29521482 [TBL] [Abstract][Full Text] [Related]
53. Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy. Arsenault F; Beauregard JM; Pouliot F Curr Opin Support Palliat Care; 2018 Sep; 12(3):359-365. PubMed ID: 29939893 [TBL] [Abstract][Full Text] [Related]
54. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy. Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024 [TBL] [Abstract][Full Text] [Related]
55. 68Ga-PSMA PET/CT False-Positive Tracer Uptake in Paget Disease. Sasikumar A; Joy A; Nanabala R; Pillai MR; T A H Clin Nucl Med; 2016 Oct; 41(10):e454-5. PubMed ID: 27556797 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging. Kabasakal L; Demirci E; Ocak M; Akyel R; Nematyazar J; Aygun A; Halac M; Talat Z; Araman A Nucl Med Commun; 2015 Jun; 36(6):582-7. PubMed ID: 25738559 [TBL] [Abstract][Full Text] [Related]